IDEAYA Biosciences ( (IDYA) ) has shared an update.
On March 28, 2025, Susan L. Kelley, M.D. notified IDEAYA Biosciences of her decision not to seek re-election to the Board of Directors at the 2025 annual meeting of stockholders. Dr. Kelley will resign from the Board at the end of her current term but will transition to an advisory role as Chair of the new Clinical Advisory Board. The company plans to reduce the Board size to seven directors after the meeting, and Dr. Kelley’s decision is not due to any disagreement with the company’s operations or policies.
More about IDEAYA Biosciences
YTD Price Performance: -41.30%
Average Trading Volume: 943,396
Technical Sentiment Signal: Buy
Current Market Cap: $1.43B
For detailed information about IDYA stock, go to TipRanks’ Stock Analysis page.